Skip to main content
Top
Published in: Abdominal Radiology 3/2019

01-03-2019

Evaluation of hepatocellular carcinoma ablative margins using fused pre- and post-ablation hepatobiliary phase images

Authors: Nobuyuki Takeyama, Naruki Mizobuchi, Masashi Sakaki, Yu Shimozuma, Jiro Munechika, Atsushi Kajiwara, Manabu Uchikoshi, Syojiro Uozumi, Yoshimitsu Ohgiya, Takehiko Gokan

Published in: Abdominal Radiology | Issue 3/2019

Login to get access

Abstract

Purpose

To retrospectively evaluate the utility of fusion images of pre- and post-ablation hepatobiliary phase (HBP) series to assess the ablation margins after radiofrequency ablation (RFA) of hepatocellular carcinomas (HCCs). Additionally, to identify factors indicative of an adequate ablation margin and predictors of local tumor progression (LTP).

Methods

Fifty-nine HCCs in 29 patients were treated by RFA and followed-up for > 1 year (mean 37.9 months). Fusion images of pre- and post-ablation HBP series were created using a non-rigid registration and manual correlation. The ablation margin appearance was classified as ablation margin + (ablation margin completely surrounding the tumor), ablation margin-zero (a partially discontinuous ablation margin without protrusion of HCC), ablation margin—(a partially discontinuous ablation margin with protrusion of HCC), and indeterminate (index tumor was not visible). The minimal ablation margin was measured, and clinical factors were examined to identify other risk factors for LTP.

Results

LTP was observed at follow-up in 12 tumors. The mean minimal ablation margin was 3.6 mm. Multivariate analysis revealed that the ablation margin status was the only significant factor (p = 0.028). The cumulative LTP rates (3.3%, 3.3%, and 3.3% at 1, 2, and 3 years, respectively) in 30 ablation margin + nodules were significantly lower (p = 0.006) than those (20.0%, 28.0%, and 32.2% at 1, 2, and 3 years, respectively) in 25 ablation margin-zero nodules.

Conclusions

Fusion images enable an early assessment of the ablation efficacy in the majority of HCCs. The ablation margin status is a significant factor for LTP.
Literature
1.
go back to reference Shiina S, Tateishi R, Arano T, et al. (2012) Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol 107:569–577CrossRefPubMed Shiina S, Tateishi R, Arano T, et al. (2012) Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol 107:569–577CrossRefPubMed
2.
go back to reference Nakazawa T, Kokubu S, Shibuya A, et al. (2007) Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol 188:480–488CrossRefPubMed Nakazawa T, Kokubu S, Shibuya A, et al. (2007) Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol 188:480–488CrossRefPubMed
3.
go back to reference Kim YS, Lee WJ, Rhim H, et al. (2010) The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment. AJR Am J Roentgenol 195:758–765CrossRefPubMed Kim YS, Lee WJ, Rhim H, et al. (2010) The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment. AJR Am J Roentgenol 195:758–765CrossRefPubMed
4.
go back to reference Kei SK, Rim H, Choi D, et al. (2008) Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence. AJR Am J Roentgenol 190:1544–1551CrossRefPubMed Kei SK, Rim H, Choi D, et al. (2008) Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence. AJR Am J Roentgenol 190:1544–1551CrossRefPubMed
5.
go back to reference M-h Park, Rhim H, Kim YS, et al. (2008) Spectrum of CT findings after radiofrequency ablation of hepatic tumors. RadioGraphics 28:379–392CrossRef M-h Park, Rhim H, Kim YS, et al. (2008) Spectrum of CT findings after radiofrequency ablation of hepatic tumors. RadioGraphics 28:379–392CrossRef
6.
go back to reference Minami Y, Nishida N, Kudo M (2014) Therapeutic response assessment of RFA for HCC: Contrast-enhanced US, CT and MRI. World J Gastroenterol 21:4160–4166CrossRef Minami Y, Nishida N, Kudo M (2014) Therapeutic response assessment of RFA for HCC: Contrast-enhanced US, CT and MRI. World J Gastroenterol 21:4160–4166CrossRef
7.
go back to reference Tomonari A, Tsuji K, Yamazaki H, et al. (2013) Feasibility of fused imaging for the evaluation of radiofrequency ablative margin for hepatocellular carcinoma. Hepatol Res 43:728–734CrossRefPubMed Tomonari A, Tsuji K, Yamazaki H, et al. (2013) Feasibility of fused imaging for the evaluation of radiofrequency ablative margin for hepatocellular carcinoma. Hepatol Res 43:728–734CrossRefPubMed
8.
go back to reference Makino Y, Imai Y, Igura T, et al. (2013) Utility of computed tomography fusion imaging for the evaluation of the ablative margin of radiofrequency ablation for hepatocellular carcinoma and the correlation to local tumor progression. Hepatol Res 43:950–958CrossRefPubMed Makino Y, Imai Y, Igura T, et al. (2013) Utility of computed tomography fusion imaging for the evaluation of the ablative margin of radiofrequency ablation for hepatocellular carcinoma and the correlation to local tumor progression. Hepatol Res 43:950–958CrossRefPubMed
9.
go back to reference Kim KW, Lee JM, Klotz E, et al. (2011) Safety margin assessment after radiofrequency ablation of the liver using registration of preprocedure and postprocedure CT images. AJR Am J Roentgenol 196:W565–W572CrossRefPubMed Kim KW, Lee JM, Klotz E, et al. (2011) Safety margin assessment after radiofrequency ablation of the liver using registration of preprocedure and postprocedure CT images. AJR Am J Roentgenol 196:W565–W572CrossRefPubMed
10.
go back to reference Shin S, Lee JM, Kim KY, et al. (2014) Postablation assessment using follow-up registration of CT images before and after Radiofrequency Ablation (RFA): prospective evaluation of midterm therapeutic results of RFA for Hepatocellular Carcinoma. AJR Am J Roentgenol 203:70–77CrossRefPubMed Shin S, Lee JM, Kim KY, et al. (2014) Postablation assessment using follow-up registration of CT images before and after Radiofrequency Ablation (RFA): prospective evaluation of midterm therapeutic results of RFA for Hepatocellular Carcinoma. AJR Am J Roentgenol 203:70–77CrossRefPubMed
12.
go back to reference Mori K, Fukuda K, Asaoka H, et al. (2009) Radiofrequency ablation of the liver: determination of ablative margin at MR imaging with impaired clearance of ferucarbotran-feasibility study. Radiology 251:557–565CrossRefPubMed Mori K, Fukuda K, Asaoka H, et al. (2009) Radiofrequency ablation of the liver: determination of ablative margin at MR imaging with impaired clearance of ferucarbotran-feasibility study. Radiology 251:557–565CrossRefPubMed
13.
go back to reference Onishi H, Matsushita M, Murakami T, et al. (2004) MR appearances of radiofrequency thermal ablation region: histopathologic correlation with dog liver models and an autopsy case. Acad Radiol 11:1180–1189CrossRefPubMed Onishi H, Matsushita M, Murakami T, et al. (2004) MR appearances of radiofrequency thermal ablation region: histopathologic correlation with dog liver models and an autopsy case. Acad Radiol 11:1180–1189CrossRefPubMed
14.
go back to reference Khankan A, Murakami T, Onishi H, et al. (2008) Hepatocellular carcinoma treated with radiofrequency ablation: an early evaluation with magnetic resonance imaging. J Magn Reson Imaging 27:546–551CrossRefPubMed Khankan A, Murakami T, Onishi H, et al. (2008) Hepatocellular carcinoma treated with radiofrequency ablation: an early evaluation with magnetic resonance imaging. J Magn Reson Imaging 27:546–551CrossRefPubMed
15.
go back to reference Koda M, Tokunaga S, Miyoshi K, et al. (2012) Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma. Eur J Radiol 81:2730–2736CrossRefPubMed Koda M, Tokunaga S, Miyoshi K, et al. (2012) Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma. Eur J Radiol 81:2730–2736CrossRefPubMed
16.
go back to reference Kim SM, Shin SS, Lee BC, et al. (2017) Imaging evaluation of ablative margin and index tumor immediately after radiofrequency ablation for hepatocellular carcinoma: comparison between multidetector-row CT and MR imaging. Abdom Radiol 42:2527–2537CrossRef Kim SM, Shin SS, Lee BC, et al. (2017) Imaging evaluation of ablative margin and index tumor immediately after radiofrequency ablation for hepatocellular carcinoma: comparison between multidetector-row CT and MR imaging. Abdom Radiol 42:2527–2537CrossRef
17.
go back to reference Yoon JH, Lee EJ, Cha SS, et al. (2010) Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas. J Vasc Interv Radiol 21:348–356CrossRefPubMed Yoon JH, Lee EJ, Cha SS, et al. (2010) Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas. J Vasc Interv Radiol 21:348–356CrossRefPubMed
18.
go back to reference Koda M, Tokunaga S, Okamoto T, et al. (2015) Clinical usefulness of the ablative margin assessed bymagnetic resonance imaging with Gd-EOB-DTPA for radiofrequency ablation of hepatocellular carcinoma. J Hepatol 63:1360–1367CrossRefPubMed Koda M, Tokunaga S, Okamoto T, et al. (2015) Clinical usefulness of the ablative margin assessed bymagnetic resonance imaging with Gd-EOB-DTPA for radiofrequency ablation of hepatocellular carcinoma. J Hepatol 63:1360–1367CrossRefPubMed
19.
go back to reference Takeyama N, Vidhyarkorn S, Chung DJ, et al. (2016) Does hepatobiliary phase sequence qualitatively outperform unenhanced T1-weighted imaging in assessment of the ablation margin 24 hours after thermal ablation of hepatocellular carcinomas? Abdom Radiol 41:1942–1955CrossRef Takeyama N, Vidhyarkorn S, Chung DJ, et al. (2016) Does hepatobiliary phase sequence qualitatively outperform unenhanced T1-weighted imaging in assessment of the ablation margin 24 hours after thermal ablation of hepatocellular carcinomas? Abdom Radiol 41:1942–1955CrossRef
20.
go back to reference Makino Y, Imai Y, Igura T, et al. (2015) Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma. Abdom Imaging 40:102–111CrossRefPubMed Makino Y, Imai Y, Igura T, et al. (2015) Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma. Abdom Imaging 40:102–111CrossRefPubMed
21.
go back to reference Sakakibara M, Ohkawa K, Katayama K, et al. (2015) Three-dimensional registration of images obtained before and after radiofrequency ablation of hepatocellular carcinoma to assess treatment adequacy. AJR Am J Roentgenol 202:W487–W495CrossRef Sakakibara M, Ohkawa K, Katayama K, et al. (2015) Three-dimensional registration of images obtained before and after radiofrequency ablation of hepatocellular carcinoma to assess treatment adequacy. AJR Am J Roentgenol 202:W487–W495CrossRef
22.
go back to reference Wang XL, Li K, Su ZZ, et al. (2015) Assessment of radiofrequency ablation margin by MRI-MRI image fusion in hepatocellular carcinoma. World J Gastroenterol 21:5345–5351CrossRefPubMedPubMedCentral Wang XL, Li K, Su ZZ, et al. (2015) Assessment of radiofrequency ablation margin by MRI-MRI image fusion in hepatocellular carcinoma. World J Gastroenterol 21:5345–5351CrossRefPubMedPubMedCentral
23.
go back to reference Boas FE, Do B, Louie JD (2015) Optimal imaging surveillance schedules after liver-directed therapy for hepatocellular carcinoma. J Vasc Interv Radiol 26:69–73CrossRefPubMed Boas FE, Do B, Louie JD (2015) Optimal imaging surveillance schedules after liver-directed therapy for hepatocellular carcinoma. J Vasc Interv Radiol 26:69–73CrossRefPubMed
25.
go back to reference Kubo M, Matsui O, Sakamoto M, et al. (2013) Role of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the management of hepatocellular carcinoma: consensus at the Symposium of the 48th Annual Meeting of the Liver Cancer. Oncology 84(suppl 1):21–27 Kubo M, Matsui O, Sakamoto M, et al. (2013) Role of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the management of hepatocellular carcinoma: consensus at the Symposium of the 48th Annual Meeting of the Liver Cancer. Oncology 84(suppl 1):21–27
26.
go back to reference Lee SR, Kilcoyne A, Kambadakone A, Arellano R (2016) Interventional Oncology: pictorial review of post-ablation imaging of liver and renal tumor. Abdom Radiol 41:677–705CrossRef Lee SR, Kilcoyne A, Kambadakone A, Arellano R (2016) Interventional Oncology: pictorial review of post-ablation imaging of liver and renal tumor. Abdom Radiol 41:677–705CrossRef
27.
go back to reference Dromain C, De Baere T, Elias D, et al. (2002) Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 223:255–262CrossRefPubMed Dromain C, De Baere T, Elias D, et al. (2002) Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 223:255–262CrossRefPubMed
28.
go back to reference Liu CH, Arellano RS, Uppot RN, et al. (2010) Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression. Eur Radiol 20:877–885CrossRefPubMed Liu CH, Arellano RS, Uppot RN, et al. (2010) Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression. Eur Radiol 20:877–885CrossRefPubMed
29.
go back to reference Kudo M (2004) Local ablation therapy for hepatocellular carcinoma: current status and future perspectives. J Gastroenterol 39:205–214CrossRefPubMed Kudo M (2004) Local ablation therapy for hepatocellular carcinoma: current status and future perspectives. J Gastroenterol 39:205–214CrossRefPubMed
30.
go back to reference Koda M, Tokunaga S, Miyoshi K, et al. (2013) Ablative margin states by magnetic resonance imaging with ferucarbotran in radiofrequency ablation for hepatocellular carcinoma can predict local tumor progression. J Gastroenterol 48:1283–1292CrossRefPubMed Koda M, Tokunaga S, Miyoshi K, et al. (2013) Ablative margin states by magnetic resonance imaging with ferucarbotran in radiofrequency ablation for hepatocellular carcinoma can predict local tumor progression. J Gastroenterol 48:1283–1292CrossRefPubMed
31.
go back to reference Kim YS, Rim H, Lim HK, et al. (2011) Coagulation necrosis induced by radiofrequency ablation in the liver: histopathologic and radiologic review of usual to extremely rare changes. Radiographics 31:377–390CrossRefPubMed Kim YS, Rim H, Lim HK, et al. (2011) Coagulation necrosis induced by radiofrequency ablation in the liver: histopathologic and radiologic review of usual to extremely rare changes. Radiographics 31:377–390CrossRefPubMed
32.
go back to reference Higaki A, Ito K, Tamada T, et al. (2014) Prognosis of small hepatocellular nodules detected only at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MR imaging as hypointensity in cirrhosis or chronic hepatitis. Eur Radiol 24:2476–2481CrossRefPubMed Higaki A, Ito K, Tamada T, et al. (2014) Prognosis of small hepatocellular nodules detected only at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MR imaging as hypointensity in cirrhosis or chronic hepatitis. Eur Radiol 24:2476–2481CrossRefPubMed
33.
go back to reference Chang WC, Chen RC, Chou CT, et al. (2014) Histological grade of hepatocellular carcinoma correlates with arterial enhancement on gadoxetic acid-enhanced and diffusion-weighted MR images. Abdom Imaging 39:1202–1212CrossRefPubMed Chang WC, Chen RC, Chou CT, et al. (2014) Histological grade of hepatocellular carcinoma correlates with arterial enhancement on gadoxetic acid-enhanced and diffusion-weighted MR images. Abdom Imaging 39:1202–1212CrossRefPubMed
Metadata
Title
Evaluation of hepatocellular carcinoma ablative margins using fused pre- and post-ablation hepatobiliary phase images
Authors
Nobuyuki Takeyama
Naruki Mizobuchi
Masashi Sakaki
Yu Shimozuma
Jiro Munechika
Atsushi Kajiwara
Manabu Uchikoshi
Syojiro Uozumi
Yoshimitsu Ohgiya
Takehiko Gokan
Publication date
01-03-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 3/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-018-1800-0

Other articles of this Issue 3/2019

Abdominal Radiology 3/2019 Go to the issue

Classics in Abdominal Radiology

The double wrinkled colon sign